CLOZAPINE FOR USE IN TREATING PATHOGENIC IMMUNOGLOBULIN DRIVEN B CELL DISEASE Application WO-2021019249-A1 World Intellectual Property Organisation (WIPO) 04 Feb 2021
Methods for predicting post-operative recurrence of Crohn's disease Grant US-10697961-B2 United States of America 30 Jun 2020
CLOZAPINE FOR THE TREATMENT OF A IMMUNOGLOBULIN DRIVEN B CELL DISEASE Application WO-2019149862-A1 World Intellectual Property Organisation (WIPO) 08 Aug 2019